Online citations, reference lists, and bibliographies.
← Back to Search

Primary Lung Cancer And Pleural Effusion—diagnostic And Therapeutic Approach

G. Hardavella, I. Karampinis
Published 2020 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Suspected and confirmed malignant pleural effusions (MPEs) due to lung cancer constitute a common yet serious clinical problem encountered in acute health care settings and are related to poor quality of life and prolonged hospital stay. This article attempts to provide a concise overview of current management and treatment approaches for confirmed and/or suspected MPEs secondary to lung cancer.
This paper references
10.1155/2013/731352
Role of blind closed pleural biopsy in the managment of pleural exudates.
Marco F. Pereyra (2013)
10.1136/thx.2010.136994
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
M. Roberts (2010)
10.1097/00132980-200310000-00003
Pleural diseases.
R. Light (1992)
10.1007/s00408-016-9933-9
Ultrasound-Guided Abrams Pleural Biopsy vs CT-Guided Tru-Cut Pleural Biopsy in Malignant Pleural Disease, a 3-Year Follow-up Study
P. Sivakumar (2016)
10.1378/chest.12-1292
A new, simple method for estimating pleural effusion size on CT scans.
M. Moy (2013)
10.1001/jama.2012.5535
Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
H. E. Davies (2012)
10.1111/resp.12496
Clinical features and survival of lung cancer patients with pleural effusions
J. M. Porcel (2015)
10.1111/j.1440-1843.2004.00599.x
Radiology in pleural disease: State of the art
A. L. Evans (2004)
10.1183/16000617.0020-2016
Advanced medical interventions in pleural disease
R. Bhatnagar (2016)
10.1002/14651858.CD002916.PUB2
Pleurodesis for malignant pleural effusions.
P. Shaw (2004)
10.21147/j.issn.1000-9604.2016.06.07
ALK gene expression status in pleural effusion predicts tumor responsiveness to crizotinib in Chinese patients with lung adenocarcinoma
Z. Wang (2016)
10.1016/j.acra.2015.03.015
CT volumetric analysis of pleural effusions: a comparison with thoracentesis volumes.
David Chiao (2015)
10.1136/thx.2010.137018
Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010
N. Rahman (2010)
Diffusion-weighted imaging can differentiate between malignant and benign pleural diseases. Cancers (Basel) 2019
K Usuda (2019)
10.1148/RADIOGRAPHICS.17.1.9017800
Complex disease of the pleural space: radiographic and CT evaluation.
J. Kuhlman (1997)
10.1159/000360769
Indwelling Pleural Catheters
R. Bhatnagar (2014)
10.1097/LBR.0B013E31804F5AA6
Natural History of Asymptomatic Pleural Effusions in Lung Cancer Patients
A. Tremblay (2007)
10.1001/jama.2019.19997
Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
R. Bhatnagar (2019)
10.1136/thoraxjnl-2014-205285
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
A. Clive (2014)
10.1136/bmjopen-2014-007045
Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial
R. Bhatnagar (2014)
10.4143/crt.2017.378
EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
Jiyoul Yang (2018)
10.1164/AJRCCM/138.1.184
State of the art. The pleura.
S. Sahn (1988)
10.1148/RADIOLOGY.191.3.8184046
Quantification of pleural effusions: sonography versus radiography.
K. Eibenberger (1994)
10.1136/thoraxjnl-2014-206054
Role of CT in assessing pleural malignancy prior to thoracoscopy
R. J. Hallifax (2014)
10.1164/rccm.201807-1415ST
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline
D. Feller-Kopman (2018)
10.1016/J.CCM.2006.02.001
Imaging of pleural disease.
N. R. Qureshi (2006)
10.1378/CHEST.127.3.909
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
C. Dresler (2005)
10.1097/MCP.0b013e3281214492
Therapeutic thoracentesis: the role of ultrasound and pleural manometry
D. Feller-Kopman (2007)
10.1016/S0140-6736(03)13079-6
Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial
N. Maskell (2003)
10.1001/jama.2017.17426
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial
Rajesh Thomas (2017)
10.1016/j.rmed.2017.02.013
State-of-the-art: Radiological investigation of pleural disease.
R. Hallifax (2017)
10.1148/RG.241035058
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
Z. Wang (2004)
10.1378/chest.12-3103
Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study.
E. Fysh (2013)
10.7326/0003-4819-114-4-271
Thoracoscopy for the diagnosis of pleural disease.
R. Menzies (1991)
10.1136/thx.2008.100545
Thoracic ultrasound in the diagnosis of malignant pleural effusion
N. R. Qureshi (2008)
[Pleural effusions].
G. Pescetti (1965)
Talc powder vs doxycycline in the control of malignant pleural effusion: a prospective, randomized trial.
J. Kużdżał (2003)
Medical thoracoscopy in the diagnosis and treatment of lung/pleural disease: Sharing an experience of 1125 cases
G. Hardavella (2013)
10.1016/j.athoracsur.2018.02.044
Efficacy and Cost of Awake Thoracoscopy and Video-Assisted Thoracoscopic Surgery in the Undiagnosed Pleural Effusion.
Christine M. McDonald (2018)
10.1046/j.1440-1843.2000.00235.x
A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions
K. Ong (2000)
10.1200/JCO.2013.50.5453
Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.
Jeong-Seon Ryu (2014)
10.1378/chest.14-0299
Physician-based ultrasound-guided biopsy for diagnosing pleural disease.
R. Hallifax (2014)
10.1016/S1470-2045(18)30294-8
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis.
I. Psallidas (2018)
10.1007/s11606-010-1472-0
Efficacy and Safety of Tunneled Pleural Catheters in Adults with Malignant Pleural Effusions: A Systematic Review
Margaret E. M. Van Meter (2010)
10.1183/13993003.00349-2018
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2018)
10.1371/journal.pone.0161764
The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion
Yajuan Sun (2016)
Pleural poudrage: new technique for the deliberate production of pleural adhesion as preliminary to lobectomy
N. Bethune (1935)
10.1159/000485934
Procedures Performed during Hospitalizations for Malignant Pleural Effusions: Data from the 2012 National Inpatient Sample
M. Fortin (2018)
10.1148/RADIOGRAPHICS.22.1.G02JAE1E1
Transthoracic US of the chest: clinical uses and applications.
D. Koh (2002)
10.1378/chest.14-0820
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
J. M. Porcel (2015)
10.7314/APJCP.2014.15.11.4629
Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography.
K. Usuda (2014)
10.1097/MCP.0000000000000389
Surgery as part of radical treatment for malignant pleural mesothelioma
D. Waller (2017)
Expert review of respiratory medicine surgical and nonsurgical management of malignant pleural effusions
DB Fitzgerald (2020)
Diagnostic ability of FDGPET/CT in the detection of malignant pleural effusion
R Nakajima (2015)
10.1378/chest.13-1187
Diagnostic accuracy and safety of semirigid thoracoscopy in exudative pleural effusions: a meta-analysis.
R. Agarwal (2013)
10.1007/s11604-011-0023-x
Diffusion-weighted imaging findings of mucinous carcinoma arising in the ano-rectal region: comparison of apparent diffusion coefficient with that of tubular adenocarcinoma
K. Nasu (2011)
Cite this article as: Hardavella G, Karampinis I. Primary lung cancer and pleural effusion-diagnostic and therapeutic approach
(2020)
10.1016/S0084-3873(11)00245-8
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
M. Raza (2011)
10.1056/NEJMc1803858
Pleural Disease.
Houriya Ayoubieh (2018)
10.21037/jtd.2017.07.79
Diagnosis and management of malignant pleural effusions: state of the art in 2017.
Neeraj R. Desai (2017)
Diffusion-weighted imaging can differentiate between malignant and benign pleural diseases. Cancers (Basel)
K Usuda



Semantic Scholar Logo Some data provided by SemanticScholar